Esrum Biotech ApS: Financial statements 2024
CVR: 43131761
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Esrum Biotech ApS (CVR 43131761) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,762,824 and a net result of DKK 1,202,026 compared with DKK 1,458,238 the year before. That is a decrease of 12.2% compared with the year before. Equity in the 2024 report amounted to DKK 3,589,001. The solvency ratio was 98.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,762,824
- Profit/Loss
- DKK 1,202,026
- Equity
- DKK 3,589,001
- Total Assets
- DKK 3,637,826
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.8 mio. | 1.2 mio. | 3.6 mio. | 1 |
| 2023 | - | 2 mio. | 1.5 mio. | 2.4 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of April 25, 2024, Esrum Biotech Holding ApS is registered as an owner of Esrum Biotech ApS with an ownership share of 100%.
Esrum Biotech ApS has published its annual report for 2023. Gross profit came to DKK 2,008,743, and the net result was DKK 1,458,238.
About Esrum Biotech ApS
Esrum Biotech ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2022. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mette Kirstine Agger. The company is owned by Esrum Biotech Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 246,808 and a net result of DKK 95,817 compared with DKK 1,202,026 the year before. Equity in the 2025 report amounted to DKK 135,817.